68Ga-5, 10, 15, 20-Tetrakis (2, 4, 6-trimethoxy phenyl) porphyrin: a novel radio-labeled porphyrin complex for positron emission tomography

Hypervalent Phosphorus(V) Porphyrins with meso-Methoxyphenyl Substituents: Significance of the Number and Position of Methoxy Groups in Promoting Intramolecular Charge Transfer

To study the photophysical and redox properties as a function of meso-aryl units, a series of hypervalent phosphorus(V) porphyrins, PP(OMe)₂·PF₆, PMP(OMe)₂·PF₆, PDMP(OMe)₂·PF₆, P345TMP(OMe)₂·PF₆, and P246TMP(OMe)₂·PF₆, with phenyl (P), 4-methoxyphenyl (MP), 3,5-dimethoxyphenyl (DMP), 3,4,5-trimethoxyphenyl (345TMP), and 2,4,6-trimethoxyphenyl (246TMP) units, respectively, have been synthesized. The P(+5) in the cavity makes the porphyrin ring electron-poor, whereas the methoxy groups make the meso-phenyl rings electron-rich. The presence of electron-rich and electron-poor portions within the porphyrin molecule promoted an intramolecular charge transfer (ICT). Also, the study suggests that the ICT depends on the number and position of the methoxy groups. The ICT is more prominent in m-methoxy-substituted phosphorus(V) porphyrins (PDMP(OMe)₂.PF₆, P345TMP(OMe)₂·PF₆) and almost no ICT was found in no-methoxy, o-methoxy, and/or p-methoxy phosphorus(V) porphyrins (PP(OMe)₂·PF₆, PMP(OMe)₂·PF₆, P246TMP(OMe)₂·PF₆). Transient absorption studies indicate that the ICT takes place on the picosecond time scale. The most striking results come from P246TMP(OMe)₂·PF₆, where each phenyl ring carries three methoxy units, like the P345TMP(OMe)₂·PF₆, but it failed to induce the ICT process. Electrochemical studies and time-dependent density functional theory (TD-DFT) calculations were used to support the experimental results. This study extensively explores why and how slight variations in meso-aryl substitutions lead to intricate changes in the photophysical and redox properties of phosphorus(V) porphyrins.

Secure transplantation by tissue purging using photodynamic therapy to eradicate malignant cells

The field of photodynamic therapy (PDT) for treating various malignant neoplasms has been given researchers' attention due to its ability to be a selective and minimally invasive cancer therapy strategy. The possibility of tumor cell infection and hence high recurrence rates in cancer patients tends to restrict autologous transplantation. So, the photodynamic tissue purging process, which consists of selective photoinactivation of the malignant cells in the graft, is defined as a compromising strategy to purify contaminated tissues before transplantation. In this strategy, the direct malignant cells' death results from the reactive oxygen species (ROS) generation through the activation of a photosensitizer (PS) by light exposure in the presence of oxygen. Since new PS generations can effectively penetrate the tissue, PDT could be an ideal ex vivo tissue purging protocol that eradicates cancer cells derived from various malignancies. The challenge is that the applied pharmacologic ex vivo tissue purging should efficiently induce tumor cells with minor influence on normal tissue cells. This review aims to provide an overview of the current status of the most effective PDT strategies and PS development concerning their potential application in ex vivo purging before hematopoietic stem cell or ovarian tissue transplantation.

Porphyrins as Chelating Agents for Molecular Imaging in Nuclear Medicine

Porphyrin ligands, showing a significant affinity for cancer cells, also have the ability to chelate metallic radioisotopes to form potential diagnostic radiopharmaceuticals. They can be applied in single-photon emission computed tomography (SPECT) and positron emission tomography (PET) to evaluate metabolic changes in the human body for tumor diagnostics. The aim of this paper is to present a short overview of the main metallic radionuclides complexed by porphyrin ligands and used in these techniques. These chelation reactions are discussed in terms of the complexation conditions and kinetics and the complex stability.